<DOC>
	<DOCNO>NCT01547169</DOCNO>
	<brief_summary>The study examine effect intranasally administer long-acting insulin detemir cognition person Alzheimer 's disease ( AD ) amnestic mild cognitive impairment ( aMCI ) . The rationale study derive grow evidence insulin contribute multiple brain function , insulin dysregulation contribute AD pathogenesis . Thus , therapy aim restore normal insulin signal CNS may beneficial effect brain function . Intranasal administration insulin increase insulin signal brain without raise peripheral level cause hypoglycemia . Insulin detemir insulin analogue may better action brain insulin formulation albumin bind property . The investigator test therapeutic effect intranasally-administered insulin detemir dose-finding study participant receive one two dos insulin detemir placebo three week period . The investigator test hypothesis either dose improve memory daily function person AD/aMCI compare placebo .</brief_summary>
	<brief_title>Study Nasal Insulin Fight Forgetfulness - Long-acting Insulin Detemir - 21 Days</brief_title>
	<detailed_description>It well-known insulin , hormone naturally secrete pancreas , play important physiological role regulate blood sugar level body . The investigator know insulin play many important role brain well . Insulin seem especially active part brain corresponds learn memory . Studies show people insufficient insulin brain ( , example , case Type-II diabetes ) , increasingly risk develop memory problem Alzheimer 's disease . In past study , investigator administer intravenous insulin participant find improves memory . However , particular method would practical intervention people Alzheimer 's disease due risk hypoglycemia exacerbation insulin resistance . Instead , investigator use `` intranasal '' method administration , insulin inserted device , administer intranasally . In method , insulin travel directly brain , bypass body . Our past study also demonstrate reliable way improve memory , change body 's blood glucose level . In past study , investigator use regular insulin , last 3-4 hour create similar `` spike '' insulin one would eat meal . However , normal physiology , pancreas also release small constant `` pulse '' insulin throughout day night , establish base level insulin . Accordingly , several longer-lasting type insulin available last close 10-12 hour , mimic base level insulin . The current study use long-lasting type insulin call `` insulin detemir , '' determine learn memory benefit constant supplement insulin . investigator want determine whether treatment benefit people already memory impairmentâ€”either already diagnosis Alzheimer 's disease diagnose mild cognitive impairment , condition precedes Alzheimer 's disease , whether low high dose insulin detemir effective . The investigator examine cognition , daily function , different marker Alzheimer 's disease blood outcome measure . The investigator specific aim : 1 . The investigator test hypothesis compare placebo , three week treatment intranasal insulin detemir improve cognition function adult Alzheimer 's Disease ( AD ) Mild Cognitive Impairment ( MCI ) . 2 . The investigator determine two dos intranasal insulin detemir produce great improvement cognition daily function relative placebo adult AD MCI . To examine hypothesis , investigator recruit approximately 60 participant diagnose AD MCI . They randomly select take low dose insulin detemir , high dose insulin detemir , saline ( inactive substance serve placebo ) . Cognition level daily function test begin study drug , 3 week study drug . The investigator also measure glucose tolerance take blood sample measure marker AD blood .</detailed_description>
	<mesh_term>Alzheimer Disease</mesh_term>
	<mesh_term>Cognition Disorders</mesh_term>
	<mesh_term>Mild Cognitive Impairment</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Insulin Detemir</mesh_term>
	<mesh_term>Insulin , Long-Acting</mesh_term>
	<criteria>Age 5089 Diagnosed mild cognitive impairment , mild/moderate AD Excessively high low blood pressure , heart rate BMI great 34 Preexisting diabetes control exercise Previous/current use insulin Significant elevation lipid , liver enzymes Menstrual period within last 12 month Significant neurological medical disorder ( AD ) Significant use nasal decongestant Current use antipsychotic , anticonvulsive , anxiolytic , glucocorticoid , sedative medication</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>89 Years</maximum_age>
	<verification_date>December 2012</verification_date>
	<keyword>memory</keyword>
	<keyword>intranasal insulin</keyword>
	<keyword>Alzheimer 's disease</keyword>
</DOC>